Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)
单位:[1]Gastrointestinal Cancer Center, Peking University Cancer Hospital-Beijing Cancer Hospital, Beijing, China[2]Department of Gastrointestinal Oncology, Peking University Cancer Hospital-Beijing Cancer Hospital, Beijing, China[3]Department of Surgery, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China[4]Department of Surgery, Harbin Medical University Cancer Hospital, Harbin, China[5]Department of Surgery, Fudan University Shanghai Cancer Center, Shanghai, China[6]Department of Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China[7]Department of Surgery, The First Affiliated Hospital, Zhejiang University, Zhejiang, China浙江大学医学院附属第一医院[8]Department of Surgery, Chinese PLA General Hospital, Beijing, China[9]Department of Surgery, Zhejiang Cancer Hospital, Zhejiang, China浙江省肿瘤医院[10]Department of Surgery, East Theater General Hospital of PLA, Jiangsu, China[11]Department of Surgery, Beijing Hospital, Beijing, China[12]Department of Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang, China[13]Department of Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China[14]Department of Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China[15]Department of Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China院本部中山大学附属第一医院[16]Department of Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China首都医科大学附属北京友谊医院[17]Department of Surgery, Zhongshan Hospital Fudan University, Shanghai, China[18]Department of Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院
第一作者单位:[1]Gastrointestinal Cancer Center, Peking University Cancer Hospital-Beijing Cancer Hospital, Beijing, China
推荐引用方式(GB/T 7714):
Ji J.,Shen L.,Li Z.,et al.Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)[J].ANNALS of ONCOLOGY.2019,30:877-877.
APA:
Ji, J.,Shen, L.,Li, Z.,Zhang, X.,Liang, H....&Li, Y..(2019).Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial).ANNALS of ONCOLOGY,30,
MLA:
Ji, J.,et al."Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)".ANNALS of ONCOLOGY 30.(2019):877-877